Position
ASSETMARK, INC in Regeneron Pharmaceuticals, Inc.
Back to the book · All holders of REGN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $8.69K$771.86 → $772.63
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 11.3K | $8.71M | — | — | — | 0.0% |
| Q1 2026 | 12.3K | $9.52M | $772.63 | $8.69K | $800.4K | 0.0% |